SPAC · Liquidated
Disc Medicine, Inc.
Formerly Gemini Therapeutics, Inc.
ExchangeNASDAQ
CIK1816736
Listed instruments
CommonIRON
Recent announcements
- Exhibit 99.1  Disc Medicine Receives FDA Orphan Drug Designation for Bitopertin for the Treatment of Erythropoietic ProtoporphyriaOther
- Exhibit 99.1  Disc Medicine Announces Several Presentations Across Hematology Portfolio at the 64th American Society of Hematology Annual MeetingOther
- Exhibit 99.4  Arix Bioscience plc Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini TherapeuticsDeal announced
- Exhibit 99.1 Gemini Therapeutics and Disc Medicine Announce Merger AgreementDeal announced
- Exhibit 99.1  Gemini Therapeutics Reports 2021 Financial ResultsOther
- Exhibit 99.1  Gemini Therapeutics Provides Corporate UpdateOther
Parties and sources
Every figure on this page is read from filings made with the SEC. Read the filings on EDGAR. How these numbers are derived.
Also tracked for this SPAC
The figures above are what the filings state. These are what SPAC Watch derives from them, and they are in the app.
- Risk classification and the disclosure it is drawn from
- Warrant fair value, exercise terms and redemption triggers
- Redemption history — every vote, rate and share count
- Trust runway, working capital and sponsor loans
- Institutional holders and their reported positions
- Directors, officers and the sponsor’s prior SPACs
See what the filings do not say plainly.
Trust runway, redemption history and warrant fair value for Disc Medicine, Inc. and every other SPAC on the market.
No card requiredData refreshed daily from EDGAR